News
Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can effectively combat Epstein-Barr virus (EBV)-driven lymphomas. The findings, ...
The life-saving impact of global vaccine stockpiles to address outbreaks of vaccine-preventable diseases has been ...
Physicians who champion immunization sustain herd immunity, reducing the incidence of severe diseases, hospitalizations, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results